Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | SCN4A | P35499 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | NOS2 | P35228 | 2/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | FAP | Q12884 | 1/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PPM1B | O75688 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10829027 | 0.98 | PRCP (0.45) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| SCHEMBL133135 | 0.98 | PRCP (0.45) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| SCHEMBL115996 | 0.98 | PRCP (0.45) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| SCHEMBL3330660 | 0.98 | PRCP (0.45) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL1073479 | 0.96 | PRCP (0.44) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL3530351 | 0.96 | PRCP (0.44) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL133134 | 0.96 | PRCP (0.44) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| Azetidine SCHEMBL18917062 | 0.95 | PRCP (0.43) | PRCPDPP7SCN4ASLC6A2SLC6A3 | |
| SCHEMBL135813 | 0.93 | SLC6A2 (0.44) | PRCPSLC6A2SLC6A3SLC6A4ALDH1A1 | |
| SCHEMBL1929065 | 0.93 | SLC6A2 (0.44) | PRCPSLC6A2SLC6A3SLC6A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1483408-A4 | NANOSTRUCTURES CONTAINING PNA JOINING OR FUNCTIONAL ELEMENTS | NANOFRAMES INC (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1483408-A1 | NANOSTRUCTURES CONTAINING PNA JOINING OR FUNCTIONAL ELEMENTS | Nanoframes, Inc. (US) | 2004-12-08 | — | — | EP | disclosed |
| US-6716961-B2 | Chiral peptide nucleic acids with a N-aminoethyl-d-proline backbone | ISIS INNOVATION LIMITED (GB) | 2004-04-06 | — | — | US | disclosed |
| US-20030215903-A1 | Nanostructures containing PNA joining or functional elements | NANOFRAMES INC. | 2003-11-20 | — | — | US | disclosed |
| US-20030198956-A1 | Staged assembly of nanostructures | NANOFRAMES, INC. | 2003-10-23 | — | — | US | disclosed |
| WO-2003072829-A1 | NANOSTRUCTURES CONTAINING PNA JOINING OR FUNCTIONAL ELEMENTS | NANOFRAMES, INC. (US) | 2003-09-04 | — | — | WO | disclosed |
| US-20030162699-A1 | Chiral peptide nucleic acids with a n-aminoethyl-d-proline backbone | ISIS INNOVATION LIMITED (GB) | 2003-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162699-A1 | Chiral peptide nucleic acids with a n-aminoethyl-d-proline backbone | POLL, HNRNPL, RNGTT | PRCP 598/4885DPP7 1416/4885SCN4A 4188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.